tetano
Editor, Senior Moderator
J Virol
. 2021 Sep 29;JVI0126721.
doi: 10.1128/JVI.01267-21. Online ahead of print.
Genetic and Antigenic Characterization of an Influenza A(H3N2) Outbreak in Cambodia and the Greater Mekong Subregion during the COVID-19 Pandemic, 2020
Jurre Y Siegers[SUP] 1 [/SUP], Vijaykrishna Dhanasekaran[SUP] 2 3 [/SUP], Ruopeng Xie[SUP] 2 3 [/SUP], Yi-Mo Deng[SUP] 4 [/SUP], Sarika Patel[SUP] 5 [/SUP], Vanra Ieng[SUP] 5 [/SUP], Jean Moselen[SUP] 4 [/SUP], Heidi Peck[SUP] 4 [/SUP], Ammar Aziz[SUP] 4 [/SUP], Borann Sarr[SUP] 6 [/SUP], Savuth Chin[SUP] 7 [/SUP], Seng Heng[SUP] 8 [/SUP], Asheena Khalakdina[SUP] 5 [/SUP], Michael Kinzer[SUP] 6 [/SUP], Darapheak Chau[SUP] 7 [/SUP], Philomena Raftery[SUP] 5 [/SUP], Veasna Duong[SUP] 1 [/SUP], Ly Sovann[SUP] 8 [/SUP], Ian G Barr[SUP] 4 [/SUP], Erik A Karlsson[SUP] 1 [/SUP]
Affiliations
Abstract
Introduction of non-pharmaceutical interventions to control COVID-19 in early 2020 coincided with a global decrease in active influenza circulation. However, between July and November 2020, an influenza A(H3N2) epidemic occurred in Cambodia and in other neighboring countries in the Greater Mekong Subregion in Southeast Asia. We characterized the genetic and antigenic evolution of A(H3N2) in Cambodia and found that the 2020 epidemic comprised genetically and antigenically similar viruses of Clade3C2a1b/131K/94N, but they were distinct from the WHO recommended influenza A(H3N2) vaccine virus components for 2020-2021 Northern Hemisphere season. Phylogenetic analysis revealed multiple virus migration events between Cambodia and bordering countries, with Laos PDR and Vietnam also reporting similar A(H3N2) epidemics immediately following the Cambodia outbreak: however, there was limited circulation of these viruses elsewhere globally. In February 2021, a virus from the Cambodian outbreak was recommended by WHO as the prototype virus for inclusion in the 2021-2022 Northern Hemisphere influenza vaccine. Importance The 2019 coronavirus disease (COVID-19) pandemic has significantly altered the circulation patterns of respiratory diseases worldwide and disrupted continued surveillance in many countries. Introduction of control measures in early 2020 against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection has resulted in a remarkable reduction in the circulation of many respiratory diseases. Influenza activity has remained at historically low levels globally since March 2020, even when increased influenza testing was performed in some countries. Maintenance of the influenza surveillance system in Cambodia in 2020 allowed for the detection and response to an influenza A(H3N2) outbreak in late 2020, resulting in the inclusion of this virus in the 2021-2022 Northern Hemisphere influenza vaccine.
. 2021 Sep 29;JVI0126721.
doi: 10.1128/JVI.01267-21. Online ahead of print.
Genetic and Antigenic Characterization of an Influenza A(H3N2) Outbreak in Cambodia and the Greater Mekong Subregion during the COVID-19 Pandemic, 2020
Jurre Y Siegers[SUP] 1 [/SUP], Vijaykrishna Dhanasekaran[SUP] 2 3 [/SUP], Ruopeng Xie[SUP] 2 3 [/SUP], Yi-Mo Deng[SUP] 4 [/SUP], Sarika Patel[SUP] 5 [/SUP], Vanra Ieng[SUP] 5 [/SUP], Jean Moselen[SUP] 4 [/SUP], Heidi Peck[SUP] 4 [/SUP], Ammar Aziz[SUP] 4 [/SUP], Borann Sarr[SUP] 6 [/SUP], Savuth Chin[SUP] 7 [/SUP], Seng Heng[SUP] 8 [/SUP], Asheena Khalakdina[SUP] 5 [/SUP], Michael Kinzer[SUP] 6 [/SUP], Darapheak Chau[SUP] 7 [/SUP], Philomena Raftery[SUP] 5 [/SUP], Veasna Duong[SUP] 1 [/SUP], Ly Sovann[SUP] 8 [/SUP], Ian G Barr[SUP] 4 [/SUP], Erik A Karlsson[SUP] 1 [/SUP]
Affiliations
- PMID: 34586866
- DOI: 10.1128/JVI.01267-21
Abstract
Introduction of non-pharmaceutical interventions to control COVID-19 in early 2020 coincided with a global decrease in active influenza circulation. However, between July and November 2020, an influenza A(H3N2) epidemic occurred in Cambodia and in other neighboring countries in the Greater Mekong Subregion in Southeast Asia. We characterized the genetic and antigenic evolution of A(H3N2) in Cambodia and found that the 2020 epidemic comprised genetically and antigenically similar viruses of Clade3C2a1b/131K/94N, but they were distinct from the WHO recommended influenza A(H3N2) vaccine virus components for 2020-2021 Northern Hemisphere season. Phylogenetic analysis revealed multiple virus migration events between Cambodia and bordering countries, with Laos PDR and Vietnam also reporting similar A(H3N2) epidemics immediately following the Cambodia outbreak: however, there was limited circulation of these viruses elsewhere globally. In February 2021, a virus from the Cambodian outbreak was recommended by WHO as the prototype virus for inclusion in the 2021-2022 Northern Hemisphere influenza vaccine. Importance The 2019 coronavirus disease (COVID-19) pandemic has significantly altered the circulation patterns of respiratory diseases worldwide and disrupted continued surveillance in many countries. Introduction of control measures in early 2020 against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection has resulted in a remarkable reduction in the circulation of many respiratory diseases. Influenza activity has remained at historically low levels globally since March 2020, even when increased influenza testing was performed in some countries. Maintenance of the influenza surveillance system in Cambodia in 2020 allowed for the detection and response to an influenza A(H3N2) outbreak in late 2020, resulting in the inclusion of this virus in the 2021-2022 Northern Hemisphere influenza vaccine.